Phycus Biotechnologies provides a bio-conversion platform intended to convert CO2 and divert GHG emissions from large-scale emitters. The company's platform combines microbial technology and metabolic engineering techniques that capture and convert carbon dioxide into high-valued chemical building blocks, which are found in a variety of industrial products and applications, enabling businesses to find an alternative route for recycling CO2 into fuels and chemicals economically, while reducing the overall GHG footprint.